Advertising Agencies
Compare Stocks
5 / 10Stock Comparison
HHS vs STGW vs KFRC vs MMS vs ICLR
Revenue, margins, valuation, and 5-year total return — side by side.
Advertising Agencies
Staffing & Employment Services
Specialty Business Services
Medical - Diagnostics & Research
HHS vs STGW vs KFRC vs MMS vs ICLR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Advertising Agencies | Advertising Agencies | Staffing & Employment Services | Specialty Business Services | Medical - Diagnostics & Research |
| Market Cap | $21M | $1.64B | $790M | $3.64B | $9.54B |
| Revenue (TTM) | $160M | $2.96B | $1.33B | $5.32B | $8.10B |
| Net Income (TTM) | $-811K | $19M | $35M | $373M | $599M |
| Gross Margin | 41.2% | 34.6% | 27.2% | 24.6% | 26.9% |
| Operating Margin | 0.7% | 5.1% | 3.8% | 10.8% | 12.2% |
| Forward P/E | — | 6.2x | 18.0x | 7.8x | 10.5x |
| Total Debt | $22M | $1.61B | $70M | $1.44B | $3.60B |
| Cash & Equiv. | $6M | $105M | $2M | $260M | $539M |
HHS vs STGW vs KFRC vs MMS vs ICLR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Harte Hanks, Inc. (HHS) | 100 | 121.9 | +21.9% |
| Stagwell Inc. (STGW) | 100 | 489.4 | +389.4% |
| Kforce Inc. (KFRC) | 100 | 143.1 | +43.1% |
| Maximus, Inc. (MMS) | 100 | 92.6 | -7.4% |
| ICON Public Limited… (ICLR) | 100 | 74.2 | -25.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HHS vs STGW vs KFRC vs MMS vs ICLR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HHS lags the leaders in this set but could rank higher in a more targeted comparison.
STGW is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 2.4%, EPS growth 464.1%, 3Y rev CAGR 2.7%
- 2.4% revenue growth vs HHS's -13.9%
- Lower P/E (6.2x vs 10.5x)
KFRC carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 8 yrs, beta 0.53, yield 3.6%
- 195.5% 10Y total return vs STGW's -60.6%
- Lower volatility, beta 0.53, Low D/E 56.0%, current ratio 1.78x
- Beta 0.53, yield 3.6%, current ratio 1.78x
MMS is the clearest fit if your priority is valuation efficiency.
- PEG 0.77 vs ICLR's 1.50
ICLR ranks third and is worth considering specifically for quality.
- 7.4% margin vs HHS's -0.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 2.4% revenue growth vs HHS's -13.9% | |
| Value | Lower P/E (6.2x vs 10.5x) | |
| Quality / Margins | 7.4% margin vs HHS's -0.5% | |
| Stability / Safety | Beta 0.53 vs ICLR's 1.60 | |
| Dividends | 3.6% yield, 8-year raise streak, vs MMS's 1.8%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +18.9% vs HHS's -42.2% | |
| Efficiency (ROA) | 9.2% ROA vs HHS's -0.9%, ROIC 19.1% vs 4.4% |
HHS vs STGW vs KFRC vs MMS vs ICLR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
HHS vs STGW vs KFRC vs MMS vs ICLR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
KFRC leads in 3 of 6 categories
ICLR leads 1 • HHS leads 1 • STGW leads 0 • MMS leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ICLR leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ICLR is the larger business by revenue, generating $8.1B annually — 50.8x HHS's $160M. ICLR is the more profitable business, keeping 7.4% of every revenue dollar as net income compared to HHS's -0.5%. On growth, STGW holds the edge at +8.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $160M | $3.0B | $1.3B | $5.3B | $8.1B |
| EBITDAEarnings before interest/tax | $6M | $358M | $56M | $645M | $1.4B |
| Net IncomeAfter-tax profit | -$811,000 | $19M | $35M | $373M | $599M |
| Free Cash FlowCash after capex | -$4M | $275M | $43M | $372M | $996M |
| Gross MarginGross profit ÷ Revenue | +41.2% | +34.6% | +27.2% | +24.6% | +26.9% |
| Operating MarginEBIT ÷ Revenue | +0.7% | +5.1% | +3.8% | +10.8% | +12.2% |
| Net MarginNet income ÷ Revenue | -0.5% | +0.6% | +2.6% | +7.0% | +7.4% |
| FCF MarginFCF ÷ Revenue | -2.3% | +9.3% | +3.3% | +7.0% | +12.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | -15.4% | +8.0% | +0.1% | -4.1% | +0.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +190.9% | -29.3% | +2.2% | +6.5% | -98.7% |
Valuation Metrics
HHS leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 12.1x trailing earnings, MMS trades at a 79% valuation discount to STGW's 58.7x P/E. Adjusting for growth (PEG ratio), MMS offers better value at 1.19x vs ICLR's 1.87x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $21M | $1.6B | $790M | $3.6B | $9.5B |
| Enterprise ValueMkt cap + debt − cash | $37M | $3.1B | $858M | $4.8B | $12.6B |
| Trailing P/EPrice ÷ TTM EPS | -25.27x | 58.73x | 22.05x | 12.10x | 13.12x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 6.18x | 17.96x | 7.83x | 10.53x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 1.19x | 1.87x |
| EV / EBITDAEnterprise value multiple | 5.64x | 7.89x | 15.42x | 6.67x | 7.95x |
| Price / SalesMarket cap ÷ Revenue | 0.13x | 0.56x | 0.59x | 0.67x | 1.15x |
| Price / BookPrice ÷ Book value/share | 1.00x | 2.13x | 6.17x | 2.31x | 1.09x |
| Price / FCFMarket cap ÷ FCF | — | 6.62x | 16.88x | 9.93x | 8.53x |
Profitability & Efficiency
KFRC leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
KFRC delivers a 27.2% return on equity — every $100 of shareholder capital generates $27 in annual profit, vs $-4 for HHS. ICLR carries lower financial leverage with a 0.38x debt-to-equity ratio, signaling a more conservative balance sheet compared to STGW's 2.00x. On the Piotroski fundamental quality scale (0–9), MMS scores 8/9 vs HHS's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -3.9% | +2.5% | +27.2% | +21.8% | +6.3% |
| ROA (TTM)Return on assets | -0.9% | +0.4% | +9.2% | +8.8% | +3.6% |
| ROICReturn on invested capital | +4.4% | +5.2% | +19.1% | +15.1% | +6.5% |
| ROCEReturn on capital employed | +3.4% | +6.0% | +20.1% | +17.4% | +7.8% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 6 | 4 | 8 | 7 |
| Debt / EquityFinancial leverage | 1.09x | 2.00x | 0.56x | 0.86x | 0.38x |
| Net DebtTotal debt minus cash | $17M | $1.5B | $68M | $1.2B | $3.1B |
| Cash & Equiv.Liquid assets | $6M | $105M | $2M | $260M | $539M |
| Total DebtShort + long-term debt | $22M | $1.6B | $70M | $1.4B | $3.6B |
| Interest CoverageEBIT ÷ Interest expense | 0.69x | 1.52x | — | 4.93x | 3.96x |
Total Returns (Dividends Reinvested)
Evenly matched — STGW and KFRC each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in STGW five years ago would be worth $13,184 today (with dividends reinvested), compared to $5,388 for HHS. Over the past 12 months, KFRC leads with a +18.9% total return vs HHS's -42.2%. The 3-year compound annual growth rate (CAGR) favors STGW at 3.4% vs HHS's -21.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -9.2% | +36.6% | +39.2% | -22.5% | -33.7% |
| 1-Year ReturnPast 12 months | -42.2% | +11.2% | +18.9% | +1.1% | -10.0% |
| 3-Year ReturnCumulative with dividends | -52.3% | +10.6% | -13.8% | -11.6% | -34.1% |
| 5-Year ReturnCumulative with dividends | -46.1% | +31.8% | -16.8% | -20.4% | -45.4% |
| 10-Year ReturnCumulative with dividends | -82.7% | -60.6% | +195.5% | +39.7% | +91.0% |
| CAGR (3Y)Annualised 3-year return | -21.9% | +3.4% | -4.8% | -4.0% | -13.0% |
Risk & Volatility
KFRC leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
KFRC is the less volatile stock with a 0.53 beta — it tends to amplify market swings less than ICLR's 1.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KFRC currently trades 91.0% from its 52-week high vs HHS's 51.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.71x | 1.17x | 0.53x | 0.72x | 1.60x |
| 52-Week HighHighest price in past year | $5.39 | $7.52 | $47.48 | $100.00 | $211.00 |
| 52-Week LowLowest price in past year | $2.22 | $4.03 | $24.49 | $60.75 | $66.57 |
| % of 52W HighCurrent price vs 52-week peak | +51.6% | +85.9% | +91.0% | +66.7% | +59.2% |
| RSI (14)Momentum oscillator 0–100 | 57.0 | 47.8 | 65.6 | 35.0 | 62.1 |
| Avg Volume (50D)Average daily shares traded | 9K | 1.7M | 305K | 683K | 1.1M |
Analyst Outlook
KFRC leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: STGW as "Buy", KFRC as "Hold", MMS as "Buy", ICLR as "Buy". Consensus price targets imply 65.0% upside for MMS (target: $110) vs 19.7% for ICLR (target: $150). For income investors, KFRC offers the higher dividend yield at 3.58% vs MMS's 1.78%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | — | $8.00 | $71.00 | $110.00 | $149.63 |
| # AnalystsCovering analysts | — | 8 | 10 | 16 | 30 |
| Dividend YieldAnnual dividend ÷ price | — | — | +3.6% | +1.8% | — |
| Dividend StreakConsecutive years of raises | 0 | 3 | 8 | 2 | — |
| Dividend / ShareAnnual DPS | — | — | $1.55 | $1.19 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.3% | +8.2% | +6.4% | +12.3% | +5.2% |
KFRC leads in 3 of 6 categories (Profitability & Efficiency, Risk & Volatility). ICLR leads in 1 (Income & Cash Flow). 1 tied.
HHS vs STGW vs KFRC vs MMS vs ICLR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is HHS or STGW or KFRC or MMS or ICLR a better buy right now?
For growth investors, Stagwell Inc.
(STGW) is the stronger pick with 2. 4% revenue growth year-over-year, versus -13. 9% for Harte Hanks, Inc. (HHS). Maximus, Inc. (MMS) offers the better valuation at 12. 1x trailing P/E (7. 8x forward), making it the more compelling value choice. Analysts rate Stagwell Inc. (STGW) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HHS or STGW or KFRC or MMS or ICLR?
On trailing P/E, Maximus, Inc.
(MMS) is the cheapest at 12. 1x versus Stagwell Inc. at 58. 7x. On forward P/E, Stagwell Inc. is actually cheaper at 6. 2x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Maximus, Inc. wins at 0. 77x versus ICON Public Limited Company's 1. 50x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — HHS or STGW or KFRC or MMS or ICLR?
Over the past 5 years, Stagwell Inc.
(STGW) delivered a total return of +31. 8%, compared to -46. 1% for Harte Hanks, Inc. (HHS). Over 10 years, the gap is even starker: KFRC returned +195. 5% versus HHS's -82. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HHS or STGW or KFRC or MMS or ICLR?
By beta (market sensitivity over 5 years), Kforce Inc.
(KFRC) is the lower-risk stock at 0. 53β versus ICON Public Limited Company's 1. 60β — meaning ICLR is approximately 203% more volatile than KFRC relative to the S&P 500. On balance sheet safety, ICON Public Limited Company (ICLR) carries a lower debt/equity ratio of 38% versus 2% for Stagwell Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — HHS or STGW or KFRC or MMS or ICLR?
By revenue growth (latest reported year), Stagwell Inc.
(STGW) is pulling ahead at 2. 4% versus -13. 9% for Harte Hanks, Inc. (HHS). On earnings-per-share growth, the picture is similar: Stagwell Inc. grew EPS 464. 1% year-over-year, compared to -25. 2% for Kforce Inc.. Over a 3-year CAGR, ICLR leads at 14. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HHS or STGW or KFRC or MMS or ICLR?
ICON Public Limited Company (ICLR) is the more profitable company, earning 9.
6% net margin versus -0. 5% for Harte Hanks, Inc. — meaning it keeps 9. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ICLR leads at 13. 3% versus 1. 4% for HHS. At the gross margin level — before operating expenses — STGW leads at 36. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HHS or STGW or KFRC or MMS or ICLR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Maximus, Inc. (MMS) is the more undervalued stock at a PEG of 0. 77x versus ICON Public Limited Company's 1. 50x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Stagwell Inc. (STGW) trades at 6. 2x forward P/E versus 18. 0x for Kforce Inc. — 11. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MMS: 65. 0% to $110. 00.
08Which pays a better dividend — HHS or STGW or KFRC or MMS or ICLR?
In this comparison, KFRC (3.
6% yield), MMS (1. 8% yield) pay a dividend. HHS, STGW, ICLR do not pay a meaningful dividend and should not be held primarily for income.
09Is HHS or STGW or KFRC or MMS or ICLR better for a retirement portfolio?
For long-horizon retirement investors, Kforce Inc.
(KFRC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 53), 3. 6% yield, +195. 5% 10Y return). ICON Public Limited Company (ICLR) carries a higher beta of 1. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (KFRC: +195. 5%, ICLR: +91. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HHS and STGW and KFRC and MMS and ICLR?
These companies operate in different sectors (HHS (Communication Services) and STGW (Communication Services) and KFRC (Industrials) and MMS (Industrials) and ICLR (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: HHS is a small-cap quality compounder stock; STGW is a small-cap quality compounder stock; KFRC is a small-cap income-oriented stock; MMS is a small-cap deep-value stock; ICLR is a small-cap deep-value stock. KFRC, MMS pay a dividend while HHS, STGW, ICLR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Communication Services
- Market Cap > $100B
- Revenue Growth > 5%
- Gross Margin > 20%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.